Extra-embryonic human Wharton's jelly stem cells do not induce tumorigenesis, unlike human embryonic stem cells
Extra-embryonic human Wharton's jelly stem cells do not induce tumorigenesis, unlike human embryonic stem cells
复制标题
DOI:
10.1016/j.rbmo.2011.10.007
复制
发表时间:
2012-02-01
影响因子:
4
通讯作者:
Bongso, Ariff
中科院分区:
文献类型:
--
作者:
Gauthaman, Kalamegam;Fong, Chui-Yee;Bongso, Ariff
Tumorigenesis is the major obstacle of tissues derived from human embryonic stem cells (ESC) and human induced pluripotent stem cell (IPSC) for transplantation therapy. This prompted a search for other sources of ESC. This study isolated and characterized stem cells from the extra-embryonic human umbilical cord Wharton's jelly (WJSC). These cells are non-controversial, available in abundance, proliferative, multipotent and hypoimmunogenic. However, their tumorigenic potential has not been properly addressed. Their tumour-producing capabilities were compared with human ESC using the immunodeficient mouse model. Unlabelled human ESC + matrigel (2 x 10(6) cells/site), labelled human WJSC (red fluorescent protein; 5 x 10(6) cells/site) and unlabelled human WJSC + matrigel (5 x 10(6) cells/site) were injected via three routes (s.c., i.m. and i.p.). Animals that received human ESC + matrigel developed teratomas in 6 weeks (s.c. 85%; i.m. 75%; i.p. 100%) that contained tissues of ectoderm, mesoderm and endoderm. No animal that received human WJSC developed tumours or inflammatory reactions at the injection sites when maintained for a prolonged period (20 weeks). Human WJSC produced increases in anti-inflammatory cytokines in contrast to human ESC, which increased pro-inflammatory cytokines. Human WJSC, being hypoimmunogenic and non-tumorigenic, have the potential for safe cell-based therapies. (C) 2011, Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.